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Abstract
Here we report the first case of carbohydrate antigen (CA) 19-9-producing early gastric adenocarcinoma arising in
polyp. A solitary pedunculated polyp lesion of the stomach, measuring 26 × 20 × 20 mm, was noticed in a 76-
year-old Japanese woman due to an abdominal disorder, associated with a markedly high serum CA19-9 level
(2,172.6 U/ml). After endoscopic mucosal resection was performed, the CA19-9 level was drastically decreased and
normalized. The scanning view of immunohistochemical staining of CA19-9 exhibited a focal, not diffuse, positive-
expression in the hyperplastic epithelium and, especially, in the irregular and fused tubular glands and the
mucinous material secreted into the dilated glands. In particular, microscopic examination of the strongly CA19-9-
positive areas showed structurally atypical epithelium containing mildly to focal moderately enlarged nuclei and
prominent nucleoli with loss of cellular polarity, estimated as adenocarcinoma. No stromal invasion was evident.
Immunohistochemically, distinct nuclear stainings for p53 and Ki-67 were seen, occasionally conforming to the
CA19-9-positive atypical cells, respectively, confirmed by double immunostaining. These hyperplastic and atypical
cells were classified into the pure gastric phenotype by mucin histochemical methods. Based on these features, we
finally made a conclusive diagnosis of CA19-9-producing in situ well differentiated adenocarcinoma of gastric type
arising in hyperplastic foveolar polyp. We suggest that the markedly high serum CA 19-9 level could be indicative
of carcinoma in polyp at the very least.
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Background
It is generally accepted that malignant transformation and
progression in tumors are closely related to alterations in
cell-surface carbohydrate antigens (CAs) with frequent aber-
rant glycosylation [1]. CA19-9 is a sialylated-Lewis
a blood
group antigen which has been shown to be useful for moni-
toring malignant tumor status, including the invasive and/or
metastatic behavior of carcioma cells affecting adhesion,
motility or immunogenicity [2,3]. Monoclonal antibody 19-
9, derived from mice spleen cells immunized with human
colon adenocarcinoma cell line SW1116, can detect its anti-
gen in the serum of patients, mainly existing in mucins con-
taining a sialylated lacto-N-fucopentaose II, IV
3-a-
NeuNAc-III
4-a-Fuc-LcOse4,i nw h i c hL c O s e 4 is Galb1-
3GlcNAcb1-3Galb1-4Glc [4,5]. The existence of CA19-9-
producing gastric cancer has been suggested, defined by
three factors according to a Japanese report: first, the
patients have high serum CA19-9 levels before resection;
second, CA19-9 expression can be identified by using the
CA19-9 antibody in the resected specimens; third, the
serum CA19-9 levels are significantly decreased after resec-
tion [6]. At least 28 cases of CA19-9-producing gastric can-
cer have been reported in the Japanese literature, but none
in the English language literature [6]. Here we report an
extremely rare and the first case of a CA19-9-producing gas-
tric adenocarcinoma arising in hyperplastic foveolar polyp.
Case presentation
The patient was a 76-year-old woman, who had only
hypertension with long-term administration of
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taken Sucralfate, a drug for protection against gastric
mucosa. She complained about abdominal disorder at
the rt. lower portion, but nothing remarkable was found
in her laboratory data except for a markedly high serum
CA19-9 level (2,172.6 U/ml, normal ranges: < 37 U/ml)
by electrochemiluminescence detection method for
development of immunoassays (ECLIA; BECKMAN
COULTER, Tokyo, Japan). The other tumor markers,
such as carcino-embryonic antigen (CEA) or CA125,
were within normal limits. No remarkable change was
seen in the abdominal and chest CT. Gastrointestinal
endoscopy was performed for further investigation,
revealing a solitary pedunculated polyp lesion measuring
approximately 25 mm in the posterior wall of the lower
gastric body (Figure 1). It was estimated as type IV
according to Yamada’s classification [7]. Eleven days
after endoscopic mucosal resection, the CA19-9 level
was drastically decreased (136.4 U/ml). Moreover, it was
down to 60 U/ml 1 day after appendectomy due to
acute appendicitis (13 days after the resection), and was
within the normal limit 1 year later. The patient is alive
and well without recurrence.
Pathological findings
A gross examination of the resected specimen (Figure 1,
inset) showed a polyp measuring 26 × 20 × 20 mm, the
surface of which was focally irregular with erosion and
hemorrhage. The scanning view (Figure 2, left upper)
and low-power image (Figure 2, left lower) of Hematox-
ylin-eosin (H & E) staining demonstrated that the lesion
was covered by hyperplastic foveolar epithelium with
focally distorted, cystically dilated, or atypical change,
supported by abundant edematous fibrovascular stroma
without apparent invasive components. Additionally, the
scanning view (Figure 2, right upper) and lower-power
image (Figure 2, right lower) of immunohistochemical
staining of CA19-9 (Dako Cytomation Co., Glostrup,
Denmark, diluted 1:30) on its sequential section exhib-
ited a focal, not diffuse, positive-expression in the hyper-
plastic epithelium and, especially, in the irregular and
fused tubular glands and the mucinous material secreted
into the dilated glands. Microscopic examination of the
strongly CA19-9-positive small areas showed irregular
and fused tubular structures, associated with surface
erosion, granulation, hemorrhage, and inflammatory
infiltrate (Figure 3). These structurally atypical epithelial
cells contained mildly to focal moderately enlarged
nuclei and occasionally prominent nucleoli with loss of
cellular polarity (Figure 3). The CA19-9-positive staining
displayed not only a cytoplasmic but also an apical pat-
tern (Figure 3). Moreover, distinct nuclear staining for
p53 (Dako Cytomation Co., Glostrup, Denmark, diluted
1:30) was occasionally conforming to the CA19-9-posi-
tive atypical cells (Figure 3), and we confirmed it by
double immunostaining (CA19-9 with Vulcan Fast Red,
and p53 with DAB as a substrate, respectively) of
MACH 2 Double Stain system (Biocare Medical, LLC.,
Concord, CA, USA), revealing the distribution of both
CA19-9- and p53-positive cells (data not shown). Addi-
tionally, the Ki67 (MIB-1; Dako, diluted 1:50) labeling
index was high, more than 5% (Figure 3) compared to
hyperplastic polyps in immunohistochemistry, conform-
ing to the CA19-9-positive areas. Similarly, double
immunostaining was performed to detect the distribu-
tion of both CA19-9- and Ki-67-positive cells (CA19-9
with DAB as a substrate, and Ki-67 with Vulcan Fast
Red, respectively) by MACH 2 Double Stain system
(Biocare Medical) (data not shown). These features indi-
cated that the irregular small areas were not within
regenerative atypia, but estimated as adenocarcinoma.
No stromal invasion or vessel permeation was evident,
and surgical margin was free of atypical cells. The sche-
matic map of this adenocarcinoma arising in hyperplas-
tic foveolar polyp is summarized in Figure 4. On the
other hand, not only the hyperplastic but the atypical
epithelium was also classified into pure gastric pheno-
type according to the immunopositivity of MUC5AC
(Novocastra, Newcastle, UK, diluted 1:100) (Figure 5)
and the immunonegativity of MUC2 (Novocastra,
diluted 1:100) or CD10 (Leica, Newcastle, UK, diluted
1:20) by the mucin histochemical methods previously
described by Yao and Kabashima, et al [8]. Based on all
these findings, we finally made a conclusive diagnosis of
CA19-9-producing well differentiated adenocarcinoma
of gastric type arising in hyperplastic foveolar polyp.
1cm
Figure 1 Endoscopic and gross examination of the polyp.
Gastrointestinal endoscopy shows a solitary pedunculated polyp
lesion, classified as Yamada type IV, in the posterior wall of lower
gastric body. On gross finding of the resected specimen (inset), the
surface of this polyp, measuring 26 × 20 × 20 mm, reveals focally
irregular features with erosion and hemorrhage.
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It is well known that gastric hyperplastic polyps rarely
demonstrate malignant transformation, the incidence of
which is reported to be 0.8% to 4.5% [9,10]. The charac-
teristics of the adenocarcinoma arising in a hyperplastic
polyp have been described as predominantly well differ-
entiated histologic type, associated with intraepithelial
neoplasia, gastric phenotype the same as a preexisting
polyp, and a crucial role of p53 in malignant transfor-
mation [9,11,12]. Additionally, an increase in size is sug-
gested to be a risk factor of malignancy [9]. In the case
of a larger polyp measuring more than 20 mm, the inci-
dence of adenocarcinoma transformation has been sig-
nificantly increased up to 5.0% to 8.2% [9,13]. The
carcinoma components are thought to arise in the
surface of the polyp and extend or invade into the stalk
side in a downward growth pattern [13]. According to
the immunohistochemical analyses in 22 lesions of
epithelial neoplasia arising in gastric hyperplastic polyps
by Yao et al., 73.0% of neoplastic components were still
classified as gastric phenotype by using the same evalua-
tion methods as the present study [8]. As to p53, con-
sidered to be one of the most important gene products
in various malignancies as well as gastric cancer, its
overexpression was observed in neoplastic components
associated with carcinogenesis in an early phase,
whereas entirely negative in hyperplastic ones [8]. Addi-
tionally, higher Ki-67 labeling index, useful for the eva-
luation of proliferative activity, were also recognized
only in carcinoma components, similar to the present
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Figure 2 Scanning view and low-power image of the polyp. (H & E) The scanning view and low-power image of Hematoxylin-eosin (H & E)
staining demonstrate that the lesion is covered by hyperplastic foveolar-type epithelium with focally distorted or cystically dilated change,
supported by abundant edematous fibrovascular stroma without apparent invasive components (left upper), and small irregular and fused
tubular areas are found in the hyperplastic polyp (left lower). (CA19-9) The scanning view and lower-power image of immunohistochemical
staining of CA19-9 on its sequential section show a focal, not diffuse, positive-expression in the hyperplastic epithelium and, especially, in the
irregular and fused tubular glands (right lower) and the secreted mucinous material into the dilated glands (right upper).
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best fits the category of carcinoma in polyp.
Surprisingly, the serum CA19-9 level before mucosal
resection of the current polyp was much higher (more
than 2,000 U/ml) than that after it. In addition, CA19-9
immunohistochemical expression was detected focally in
this specimen. These features are consistent with CA19-9-
producing gastric neoplasms, characteristics of which also
are well differentiated and gastric foveolar phenotypes, but
often poor prognosis with invasion depth beyond the sub-
mucosal layer [6]. There are no previous reports of CA19-
9-producing in situ gastric cancer or CA19-9-producing
gastric cancer arising in polyp such as the present case. To
date only 5 early gastric cancer cases out of 28 CA19-9-
producing neoplasms have been reported, and
interestingly, those serum CA19-9 levels before surgery
were relatively low, less than 2,000 U/ml, unlike the cur-
rent one [6]. By contrast, little is clearly understood with
regard to the mechanism by which CA19-9 antigens in
mucins derived from gastrointestinal, colon, or pancreatic
neoplasms transfer to vascular lumens. It has been
reported that patients with acute cholangitis accompanied
by cholestasis or with gastric ulcer after long-term admin-
istration of Sucralfate rarely have high serum CA19-9
levels [14,15]. These phenomena thus suggest that any
obstructive disorder between the digestive tract lumen and
mucin-secreting epithelium could induce the CA19-9 anti-
gens to compress into the blood. As shown in Figure 2 of
the present case, CA19-9 was particularly expressed on
the accumulated mucin in the cystically dilated glands,
HE CA19-9
Ki-67
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Figure 3 Microscopic examination of the adenocarcinoma arising in polyp by hematoxylin-eosin (H & E) and immunohistochemical
stainings. (H & E) Small adenocarcinoma areas in the hyperplastic polyp show irregular and fused tubular structures, associated with surface
erosion, granulation, hemorrhage, and inflammatory infiltrate. These structurally atypical epithelial cells contain mildly to focal moderately
enlarged nuclei and occasionally prominent nucleoli with loss of cellular polarity. (CA19-9) These atypical glands are immunohistochemically
positive for CA19-9, associated with strong expression especially in the secreted mucin. The CA19-9-positive staining displays not only a
cytoplasmic but also an apical pattern. (p53) Distinct nuclear staining for p53 is occasionally conforming to these atypical cells (arrows). (Ki-67)
Moreover, Ki-67 (MIB-1) labeling index is high (more than 5% compared to hyperplastic polyps), conforming to the small adenocarcinoma areas.
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tigation with more clinical samples is necessary to deter-
mine how and whether or not the high serum CA19-9
levels are correlated with pathological findings and immu-
nohistochemical expression patterns of CA19-9. While,
the tumor cells can secrete CA19-9 even when the turn-
over of it is too rapid to accumulate and express. It is thus
possible that the expression pattern of CA19-9 immunor-
eactivity was little significance. Nevertheless, we assume
that, the serum CA19-9 level of more than 2,000 U/ml in
the present case could be indicative of malignant transfor-
mation at the very least, because overexpression of CA19-
9 results from a clonal growth of abnormal cells having
genetic and/or epigenetic disorders [1].
On the other hand, the rate of high serum CA19-9
levels before surgery among all patients with gastric
cancer is not remarkable, only 25% to 30%, and thus,
the serum CA19-9 levels are not clinically important
for a tumor marker, but only for a prognosis indicator
[3,6,14]. In that sense, since most clinicians have never
examined the serum CA19-9 levels for merely gastric
polyp lesions, CA19-9-producing gastric carcinoma in
polyp may be more common than generally
considered.
Conclusion
We herein reported the first case of a CA19-9-produ-
cing early well differentiated adenocarcinoma arising in
gastric hyperplastic foveolar polyp. We should be aware
that gastric polyp lesions might rarely produce markedly
high CA19-9 antigens, possibly associated with malig-
nant transformation.
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Figure 4 Schematic map of the adenocarcinoma arising in
polyp. The present case has been diagnosed as CA19-9 producing
gastric adenocarinoma arising in hyperplastic foveolar polyp. The
small carcinoma components (red areas) arise in the surface of the
polyp without apparent stromal invasion. Left lower side is a stalk of
the adenocarcima in polyp.
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Figure 5 Microscopic examination of the adenocarcinoma arising in polyp by mucin immunohistochemical methods.N o to n l yt h e
hyperplastic (left) but the atypical (right) epithelium is also positive for MUC5AC in immunohistochemistry whereas negative for MUC2 or CD10,
classified into pure gastric phenotype.
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